First human tests begin for experimental lung injury treatment
Disease control
Not yet recruiting
This early-stage study is testing the safety of a new antibody drug called HT31-1 in healthy volunteers. The drug is being developed to treat Acute Respiratory Distress Syndrome (ARDS), a serious lung condition often caused by infections. Researchers will give increasing doses to…
Phase: PHASE1 • Sponsor: HTIC, Inc • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC